Widman, Adam J. http://orcid.org/0000-0001-7953-0677
Shah, Minita
Frydendahl, Amanda http://orcid.org/0000-0001-9552-5421
Halmos, Daniel
Khamnei, Cole C.
Øgaard, Nadia
Rajagopalan, Srinivas
Arora, Anushri
Deshpande, Aditya
Hooper, William F.
Quentin, Jean
Bass, Jake http://orcid.org/0000-0001-8703-8877
Zhang, Mingxuan
Langanay, Theophile
Andersen, Laura http://orcid.org/0009-0001-0223-3401
Steinsnyder, Zoe
Liao, Will http://orcid.org/0000-0001-7574-4694
Rasmussen, Mads Heilskov http://orcid.org/0000-0001-5723-6303
Henriksen, Tenna Vesterman
Jensen, Sarah Østrup http://orcid.org/0000-0001-6044-3362
Nors, Jesper http://orcid.org/0000-0002-9104-7263
Therkildsen, Christina http://orcid.org/0000-0002-2833-6986
Sotelo, Jesus
Brand, Ryan http://orcid.org/0000-0001-6412-6647
Schiffman, Joshua S. http://orcid.org/0000-0002-1028-1438
Shah, Ronak H. http://orcid.org/0000-0001-9042-6213
Cheng, Alexandre Pellan http://orcid.org/0000-0002-3667-0992
Maher, Colleen http://orcid.org/0000-0003-1117-9272
Spain, Lavinia
Krause, Kate
Frederick, Dennie T. http://orcid.org/0000-0003-3355-5267
den Brok, Wendie
Lohrisch, Caroline
Shenkier, Tamara
Simmons, Christine
Villa, Diego http://orcid.org/0000-0002-4625-3009
Mungall, Andrew J. http://orcid.org/0000-0002-0905-2742
Moore, Richard
Zaikova, Elena http://orcid.org/0000-0002-2422-3108
Cerda, Viviana
Kong, Esther http://orcid.org/0000-0002-1315-4311
Lai, Daniel http://orcid.org/0000-0001-9203-6323
Malbari, Murtaza S.
Marton, Melissa
Manaa, Dina
Winterkorn, Lara
Gelmon, Karen
Callahan, Margaret K. http://orcid.org/0000-0002-9087-0012
Boland, Genevieve http://orcid.org/0000-0002-7522-6173
Potenski, Catherine
Wolchok, Jedd D. http://orcid.org/0000-0001-6718-2222
Saxena, Ashish
Turajlic, Samra http://orcid.org/0000-0001-8846-136X
Imielinski, Marcin http://orcid.org/0000-0002-2211-4741
Berger, Michael F. http://orcid.org/0000-0003-3882-5000
Aparicio, Sam http://orcid.org/0000-0002-0487-9599
Altorki, Nasser K. http://orcid.org/0000-0001-9754-9945
Postow, Michael A. http://orcid.org/0000-0002-3367-7961
Robine, Nicolas http://orcid.org/0000-0001-5698-8183
Andersen, Claus Lindbjerg http://orcid.org/0000-0002-7406-2103
Landau, Dan A. http://orcid.org/0000-0003-2346-9541
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA263301-01A1)
Melanoma Research Alliance (1039927)
Article History
Received: 21 December 2023
Accepted: 30 April 2024
First Online: 14 June 2024
Competing interests
: D.A.L., A.J.W., C.C.K. and J.B. are listed as inventors on a pending patent application (WO2023018791A1), filed by Cornell University, which is directed to methods of detecting SNVs for the purposes of MRD detection and other plasma-based cancer monitoring. D.A.L., A.J.W. and M.S. are listed as inventors on a pending patent application (WO2023133093A1), filed by Cornell University, which is directed to methods of detecting CNVs for the purposes of MRD detection and other plasma-based cancer monitoring. A.P.C. is listed as an inventor on submitted patents pertaining to cell-free DNA (US patent applications 63/237,367, 63/056,249, 63/015,095 and 16/500,929) and receives consulting fees from Eurofins Viracor. A.S. receives research funding from AstraZeneca, has served on Advisory Boards for AstraZeneca, Blueprint Medicines and Jazz Pharmaceuticals, and has been a consultant for Genentech. M.A.P. has received consulting fees from BMS, Chugai, Cancer Expert Now, Intellisphere, Merck, MJH Associates, Nektar, Pfizer, Uptodate, WebMD and Erasca, and received institutional support from RGenix, Infinity, BMS, Merck, Genentech and Novartis. C.L.A. reports collaborations with C2i Genomics and Natera. C.S. has received honoraria for advisory board participation from Pfizer, Novartis, Knight, Bayer, Merck, Roche and Lilly within the past 2 years. None of the honoraria has been in excess of CAD$5,000 and total for honoraria received is less than CAD$25,000. M.K.C. has received consulting fees from BMS, Merck, InCyte, Moderna, ImmunoCore and AstraZeneca and receives institutional support from BMS. S.T. is funded by Cancer Research UK (grant ref. no. A29911); the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC10988), the UK Medical Research Council (FC10988) and the Wellcome Trust (FC10988); the National Institute for Health Research Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research (grant ref. no. A109), the Royal Marsden Cancer Charity, The Rosetrees Trust (grant ref. no. A2204), Ventana Medical Systems (grant reference nos. 10467 and 10530), the National Institute of Health (U01 CA247439) and Melanoma Research Alliance (award ref. no. 686061). S.T. has received speaking fees from Roche, AstraZeneca, Novartis and Ipsen. S.T. has the following patents filed: Indel mutations as a therapeutic target and predictive biomarker PCTGB2018/051892 and PCTGB2018/051893. G.B. has sponsored research agreements through her institution with: Olink Proteomics, Teiko Bio, InterVenn Biosciences and Palleon Pharmaceuticals. G.B. served on advisory boards for Iovance, Merck, Nektar Therapeutics, Novartis and Ankyra Therapeutics. G.B. consults for Merck, InterVenn Biosciences, Iovance and Ankyra Therapeutics. G.B. holds equity in Ankyra Therapeutics. M.F.B. reports consulting for AstraZeneca, Eli Lilly, Paige.AI, research support from Boundless Bio and intellectual property rights for SOPHiA Genetics. J.D.W. is a consultant for Apricity, Ascentage Pharma, AstraZeneca, BeiGene, Bicara Therapeutics, Bristol Myers Squibb, Daiichi Sankyo, Dragonfly, Imvaq, Larkspur, Psioxus, Recepta, Takeda, Tizona, Trishula Therapeutics and Sellas. J.D.W. received grant/research support from Bristol Myers Squibb and Enterome. J.D.W. has Equity in Apricity, Arsenal IO/CellCarta, Ascentage, Imvaq, Linneaus, Larkspur, Georgiamune, Maverick, Tizona Therapeutics and Xenimmune. D.A.L. received research support from Illumina. D.A.L. participated in advisory boards Pangea, Mission Bio and Alethiomics. D.A.L. is a scientific co-founder of C2i Genomics. The other authors declare no competing interests.